Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

Overview of attention for article published in The Lancet, September 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#20 of 42,968)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 445 news outlets
blogs: 29 blogs
policy: 3 policy sources
twitter: 11065 X users
patent: 3 patents

peer_reviews: 1 peer review site
facebook: 20 Facebook pages
wikipedia: 35 Wikipedia pages
reddit: 5 Redditors
video: 6 YouTube creators

Citations

dimensions_citation: 887 Dimensions

Readers on

mendeley: 1433 Mendeley

Summary News Blogs Policy documents X Patents Peer reviews Facebook Wikipedia Reddit YouTube Dimensions citations

So far, Dimensions has found 887 publications that cite this research output.

887

The most recent citing publications are shown below. View all 887 publications that cite this research output on Dimensions.

Clonal structure and the specificity of vaccine-induced T cell response to SARS-CoV-2 Spike protein

Article in Frontiers in Immunology (April 2024)

Adenovirus keratoconjunctivitis after LASIK as a complication of COVID-19 vaccination: a clinical case

Article in Russian Ophthalmological Journal (March 2024)

Self-Amplifying RNA: A Second Revolution of mRNA Vaccines against COVID-19

Article in Vaccines (March 2024)